Floatz logo

FAZA

Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma

University of California, San FranciscoSmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

87 Active assets in the Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma cohort.

Asset / SponsorPhaseRating
Ifosfamide
David Bond, MD
Phase 4BBB
Inno-206
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase 4BBB
ETOPOSIDE
University of Washington
Phase 4BBB
Inno-206
University of Washington
Phase 4BBB
ETOPOSIDE
University of Washington
Phase 4BBB

View all 50 →

Same molecule, other indications

FAZA is also rated in:

Breast NeoplasmDormant
CC
Indicative ·
44 / 100
View asset →
Neuroendocrine TumoursDormant
CC
Indicative ·
41 / 100
View asset →
Renal Cell CarcinomaDormant
C
Indicative ·
36 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →